109 related articles for article (PubMed ID: 21593221)
21. Experts condemn "flawed" NICE process over its rejection of prostate cancer drug.
O'Dowd A
BMJ; 2014 Aug; 349():g5224. PubMed ID: 25139515
[No Abstract] [Full Text] [Related]
22. FDA approves new combined treatment for advanced prostate cancer.
Cancer; 2023 Dec; 129(24):3841-3842. PubMed ID: 38102101
[No Abstract] [Full Text] [Related]
23. Abiraterone and increased survival in metastatic prostate cancer.
Sonpavde G
N Engl J Med; 2011 Aug; 365(8):766-7; author reply 767-8. PubMed ID: 21864181
[No Abstract] [Full Text] [Related]
24. Agents that target androgen synthesis in castration-resistant prostate cancer.
Ferraldeschi R; de Bono J
Cancer J; 2013; 19(1):34-42. PubMed ID: 23337755
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer: score one for validated targets.
Bates SE
Clin Cancer Res; 2011 Jun; 17(12):3866. PubMed ID: 21680541
[No Abstract] [Full Text] [Related]
26. Molecular states underlying androgen receptor activation: a framework for therapeutics targeting androgen signaling in prostate cancer.
Nelson PS
J Clin Oncol; 2012 Feb; 30(6):644-6. PubMed ID: 22184375
[No Abstract] [Full Text] [Related]
27. Reply: 'Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.
Omlin A; Pezaro CJ; Zaidi S; Lorente D; Mukherji D; Bianchini D; Ferraldeschi R; Sandhu S; Dearnaley D; Parker C; Van As N; de Bono JS; Attard G
Br J Cancer; 2014 Jan; 110(1):267-8. PubMed ID: 24300975
[No Abstract] [Full Text] [Related]
28. Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.
Attard G; Belldegrun AS; de Bono JS
BJU Int; 2005 Dec; 96(9):1241-6. PubMed ID: 16287438
[No Abstract] [Full Text] [Related]
29. Degarelix (firmagon) for prostate cancer.
Med Lett Drugs Ther; 2009 Oct; 51(1323):82-3. PubMed ID: 19838145
[No Abstract] [Full Text] [Related]
30. Abiraterone in prostate cancer.
Ryan C
Clin Adv Hematol Oncol; 2010 Nov; 8(11):761-2. PubMed ID: 21326154
[No Abstract] [Full Text] [Related]
31. Comment on 'Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.
Shamash J; Sarker SJ
Br J Cancer; 2014 Jan; 110(1):266-7. PubMed ID: 24300970
[No Abstract] [Full Text] [Related]
32. New treatment options for castration-resistant prostate cancer.
Simondsen K; Kolesar J
Am J Health Syst Pharm; 2013 May; 70(10):856-65. PubMed ID: 23640346
[TBL] [Abstract][Full Text] [Related]
33. Abiraterone acetate (Zytiga) for metastatic castration-resistant prostate cancer.
Med Lett Drugs Ther; 2011 Aug; 53(1370):63-4. PubMed ID: 21836546
[No Abstract] [Full Text] [Related]
34. The role of abiraterone in the management of metastatic castration-resistant prostate cancer.
Rawlinson A; Mohammed A; Beatty J; Bell R; Miller M
Expert Rev Anticancer Ther; 2012 Apr; 12(4):429-37. PubMed ID: 22500680
[TBL] [Abstract][Full Text] [Related]
35. Drug approvals 2011: focus on companion diagnostics.
Goozner M
J Natl Cancer Inst; 2012 Jan; 104(2):84-6. PubMed ID: 22215850
[No Abstract] [Full Text] [Related]
36. Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancer.
Pinto-Bazurco Mendieta MA; Negri M; Jagusch C; Müller-Vieira U; Lauterbach T; Hartmann RW
J Med Chem; 2008 Aug; 51(16):5009-18. PubMed ID: 18672868
[TBL] [Abstract][Full Text] [Related]
37. Abiraterone and metastatic prostate cancer: delays pain onset, cytotoxic therapy, and possibly death.
Prescrire Int; 2014 Feb; 23(146):40-1. PubMed ID: 24669383
[TBL] [Abstract][Full Text] [Related]
38. FDA Approves Drug Combo for Kidney Cancer.
Cancer Discov; 2016 Jul; 6(7):687-8. PubMed ID: 27267515
[TBL] [Abstract][Full Text] [Related]
39. FDA approves prostate cancer "vaccine".
Tanne JH
BMJ; 2010 May; 340():c2431. PubMed ID: 20442242
[No Abstract] [Full Text] [Related]
40. New taxane treats advanced prostate cancer.
Thompson CA
Am J Health Syst Pharm; 2010 Aug; 67(15):1220. PubMed ID: 20651307
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
